Background. Each year, the US Influenza Vaccine Effectiveness Network estimates the effectiveness of seasonal influenza vaccine to prevent influenza-associated, medically attended acute respiratory illness.
Impact of Prior Season Influenza Vaccination on Seasonal Influenza Vaccine Effectiveness: An Analysis over Four Consecutive Seasons from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
Background. Recent controversy has arisen from observational studies suggesting a potential negative association between prior influenza vaccination and subsequent influenza vaccine effectiveness (VE). As immunologic theories suggest this impact could vary by season/strain, we investigated this association over 4 influenza seasons in Canada.
Methods. The CIRN SOS Network prospectively enrolled laboratory-confirmed influenza cases and influenza-negative controls admitted to participating hospitals. Using a test-negative control design, matched conditional logistic regression modeling stratifying participants into 4 groups (not vaccinated current or prior season [referent] , vaccinated prior season only, vaccinated current season only, and vaccinated both current and prior season) was used to calculate odds ratios (OR) to estimate the effect of vaccination status on influenza-related hospitalization (VE= 1-OR x100). We assessed VE overall and stratified by strain (A/H3N2, A/H1N1, and influenza B) for 4 influenza seasons in Canada: 2011 Canada: /2012 Canada: -2014 Canada: /2015 .
Results. Although impact of prior vaccination varied, the largest strain-specific impacts were observed in the H3N2 dominant seasons 2012/2013 and 2014/2015, seasons where the H3N2 vaccine component was matched, and mismatched, respectively, to the circulating strain. In 12/13, adjusted VE against influenza H3N2 hospitalization was 58.6% (95% Confidence Interval [CI]: 32.5-74.7%) for patients vaccinated in current season only, relative to 30.9% (10.8-46.5%) among those vaccinated in both prior and current season; VE against influenza B hospitalization in 12/13 was 83.2% (18.9-96.5%) in current season only vaccinees and 54.1% (-6.0-80.2%) in both seasons vaccinees. In 14/15, H3N2 VE was 35.3% (-32.6-68 .5%) in current season only vaccinees and -8.3% (-56.7-25 .1%) in both seasons vaccinees.
Conclusion. While our findings support a possible negative association between prior influenza vaccination and subsequent season VE against some strains in certain seasons, non-statistically significant reductions in VE were observed. Future prospective studies, using varying methodology to examine this association and to explore contributing biological/immunological mechanisms, are critical to inform immunization policy.
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